Lv0
0 积分 2026-02-05 加入
Endpoint Exposure‐Response Analyses in the Presence of Concurrent Dose Modification During Clinical Trials
9小时前
待确认
Estimating Treatment Efficacy Controlling for Subsequent Therapy Usage: Comparison of Multiple Methods and Application to Hematologic Oncology Trials
13小时前
已完结
An Instrumental Variable Approach to Learning the Causal Exposure–Response Relationship in a Randomized Dose Comparison Trial
1天前
已完结
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs
5天前
已完结
Can Bias Evaluation Provide Protection Against False‐Negative Results in QT Studies Without a Positive Control Using Exposure‐Response Analysis?
10天前
已完结
Model informed assessment of QT prolongation during drug development: a five-year retrospective analysis of EMA scientific advices
19天前
已完结
Concentration‐QTc Analysis as an Alternative to TQT Studies: Findings From QT Evaluation and Safety Labeling Decisions in Japan
22天前
已完结
Model informed assessment of QT prolongation during drug development: a five-year retrospective analysis of EMA scientific advices
23天前
已完结
QT Prolongation Risk of Antibody–Drug Conjugates
23天前
已完结
Lessons learned from QT prolongation risk assessment for antibody-drug conjugates in oncology
23天前
已完结
皖公网安备34019202002308
